211 related articles for article (PubMed ID: 15797962)
1. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
Lin-Su K; Vogiatzi MG; Marshall I; Harbison MD; Macapagal MC; Betensky B; Tansil S; New MI
J Clin Endocrinol Metab; 2005 Jun; 90(6):3318-25. PubMed ID: 15797962
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
3. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.
Lin-Su K; Harbison MD; Lekarev O; Vogiatzi MG; New MI
J Clin Endocrinol Metab; 2011 Jun; 96(6):1710-7. PubMed ID: 21450983
[TBL] [Abstract][Full Text] [Related]
4. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
[TBL] [Abstract][Full Text] [Related]
5. Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa.
Longui CA; Kochi C; Calliari LE; Modkovski MB; Soares M; Alves EF; Prudente FV; Monte O
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):661-4. PubMed ID: 22218451
[TBL] [Abstract][Full Text] [Related]
6. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
7. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results.
Cassorla F; Mericq V; Eggers M; Avila A; García C; Fuentes A; Rose SR; Cutler GB
J Clin Endocrinol Metab; 1997 Dec; 82(12):3989-92. PubMed ID: 9398701
[TBL] [Abstract][Full Text] [Related]
8. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
[TBL] [Abstract][Full Text] [Related]
9. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
13. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
[TBL] [Abstract][Full Text] [Related]
14. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.
Klein KO; Barnes KM; Jones JV; Feuillan PP; Cutler GB
J Clin Endocrinol Metab; 2001 Oct; 86(10):4711-6. PubMed ID: 11600530
[TBL] [Abstract][Full Text] [Related]
15. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia.
Javed A; Lteif A; Kumar S
Pediatr Endocrinol Rev; 2012 Nov; 10(1):164-73. PubMed ID: 23469393
[TBL] [Abstract][Full Text] [Related]
16. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
17. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
19. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
[TBL] [Abstract][Full Text] [Related]
20. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
